In an exclusive interview with Prohibition Partners, Alvaro Torres, CEO at Khiron, describes the company’s opportunities for growth in the next two years, particularly in the North American market. After recently obtaining approvals from the TSXV, Canada’s leading stock exchange, Khiron is in the process of commercializing Kuida in the US to bring more products and high-end CBD brands to the market. 

Torres also emphasizes Khiron’s brand- and patient- oriented strategy to position itself as a leader in the global market, stating that the company has focused on advancing its research, strengthening relationships with patients, doctors and consumers, and on developing high-quality products in innovative manner.  

Powered by an efficient supply chain, we aim to be the leading B2C cannabis company in each market we enter," commented Torres.

For further information refer to the original news.

Prohibition Partners. 2019. Industry Expert Interview.
                

Recovered from: